-
Arkansas State Rep. Dwight Tosh honored at St. Jude for 60-year survival of childhood cancer
06/24/2022
Tosh is the first St. Jude patient to reach this milestone and was recognized at institution’s 60th anniversary celebration
-
St. Jude collaborates with multiple organizations to expand STEM opportunities in Memphis
06/23/2022
New collaboration with multiple organizations is part of national effort to provide equity in STEM education.
-
U.S. News & World Report ranks St. Jude as outstanding pediatric cancer hospital
06/14/2022
St. Jude Children’s Research Hospital recognized among hospitals delivering exceptionally high-quality care
-
A high-risk pair – a drug and DNA variant increase heart disease risk in cancer survivors
06/13/2022
St. Jude scientists identified a genetic difference in childhood cancer survivors treated with chemotherapy that predisposes them to heart problems as adults.
-
Unfreezing waters in ligand binding sites
06/07/2022
St. Jude scientists are studying how the temperature at which protein structures are captured can create "artifacts," – errors that cause misleading results.
-
St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology
05/31/2022
Learn best practices and hear insights from St. Jude oncologists, psychologists and scientists at the annual gathering of clinical oncology experts.
-
Heterochromatin silencing is like a piano that doesn’t make a sound
05/31/2022
St. Jude scientists have a new understanding of the pathways that contribute to this gene silencing.
-
ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
05/19/2022
St. Jude scientists identified ZBP1 as a key contributor to the inflammatory cell death that drives morbidity and mortality in COVID-19 patients.
-
Updates on gene therapy for ‘bubble boy’ disease and cellular immunotherapy at ASGCT
05/12/2022
St. Jude scientists will discuss research on cellular therapies for pediatric cancer and more at the annual meeting.
-
A tool to unlock the ‘numbers game’ of big data in rare disease research
05/11/2022
Big data can cause big problems in rare disease genetics research. Scientists at St. Jude created a systematic solution to find the inherited genes contributing to rare disease.
Explore more research news
More Research News
-
Scientific Report 2021
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Promise Magazine
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.